NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma

Clinical trial NCT01894061 · COMPLETED

Trial details

NCT number: NCT01894061
Sponsor: Case Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor

Start date: 2013-09-18
Primary completion: 2019-07-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.